Publications

You can use the filters to show only results that match your interests

Filter publications
300 publications by Medicines and Healthcare products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Early access to medicines scheme applications: pending, refused, granted

    • MHRA
    • Official Statistics
  2. Suspended and revoked licences for manufacturers and wholesalers of medicines

  3. Toolkit on the risks of valproate medicines in female patients

  4. Drug Safety Update: monthly PDF newsletter

    • MHRA
    • Guidance
  5. Marketing authorisations granted in August 2016

  6. Parallel import licenses granted in August 2016

  7. Clinical trials for medicines: authorisation assessment performance

    • MHRA
    • Transparency data
  8. Herbal medicines granted a traditional herbal registration (THR)

  9. Pharmacovigilance inspection metrics, 2009 to present

  10. Human and veterinary medicines: register of licensed wholesale distribution sites

  11. Human and veterinary medicines: register of licensed manufacturing sites 2016

  12. Medicines: terminated and cancelled manufacturing and wholesale dealer licences

  13. Medicines: new manufacturing and wholesale dealer licences

  14. Register of brokers authorised to deal in human medicines

  15. Medicines and Healthcare products Regulatory Agency board member expenses from April to June 2015

    • MHRA
    • Transparency data
  16. Medicines and Healthcare products Regulatory Agency board member expenses from January to March 2016

    • MHRA
    • Transparency data
  17. Medical devices: software applications (apps)

  18. Early access to medicines scheme: expired scientific opinions

    • MHRA
    • Decision
  19. Early access to medicines scheme (EAMS) scientific opinion: pembrolizumab for non-small cell lung cancer

  20. Annual reports of the ABRHP and the HMAC

    • MHRA
    • Corporate report
  21. Early access to medicines scheme (EAMS) scientific opinion: venetoclax for the treatment of chronic lymphocytic leukaemia (CLL)

  22. Marketing authorisation granted in July 2016

  23. Parallel import licenses granted in July 2016

  24. Medicines: licensing time-based performance measures

    • MHRA
    • Official Statistics
  25. Medicines: forms to make a variation to a Blood establishment Authorisation

    • MHRA
    • Form
  26. Medicines: variation forms for a manufacturer's licence

  27. Medical devices: UK notified bodies

  28. Advertising investigations: June 2016

  29. MHRA: policy for handling conflicts of interest

    • MHRA
    • Corporate report
  30. Medicines and Healthcare Products Regulatory Agency Annual Report and Accounts 2015 to 2016

    • MHRA
    • Corporate report
  31. Human Medicines Regulations 2012 Advisory Bodies annual report 2015

    • MHRA
    • Corporate report
  32. Parallel imports of medical devices

    • MHRA
    • Guidance
  33. Marketing authorisations granted in June 2016

  34. Parallel import licences granted in June 2016

  35. Single-use medical devices

    • MHRA
    • Guidance
  36. Widening the availability of Naloxone

    • DH, PHE and MHRA
    • Guidance
  37. Medicines and Healthcare products Regulatory Agency spending over £25,000: 2015 to 2016

    • MHRA
    • Transparency data
  38. Medicines and Healthcare products Regulatory Agency GPC spending over £500: 2015 - 2016

    • MHRA
    • Transparency data
  39. Medicines and Healthcare products Regulatory Agency spending over £25,000: 2016 to 2017

    • MHRA
    • Transparency data
  40. Advertising investigations: May 2016